Impact BioMedical, Inc. (IBO)
0.4602
+0.02
(+4.35%)
USD |
NYAM |
Sep 11, 16:00
0.465
0.00 (0.00%)
After-Hours: 20:00
Impact BioMedical Price : 0.4602 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 0.4467 | 0.49 | 0.4467 | 0.4602 | 310591.0 |
| Sep 10, 2026 | 0.475 | 0.5082 | 0.4337 | 0.441 | 272464.0 |
| Sep 09, 2026 | 0.509 | 0.51 | 0.4818 | 0.4937 | 49145.00 |
| Sep 08, 2026 | 0.51 | 0.5337 | 0.50 | 0.50 | 151052.0 |
| Sep 04, 2026 | 0.48 | 0.64 | 0.47 | 0.54 | 4.134M |
| Sep 03, 2026 | 0.48 | 0.489 | 0.4701 | 0.48 | 82432.00 |
| Sep 02, 2026 | 0.4724 | 0.49 | 0.46 | 0.49 | 45116.00 |
| Sep 01, 2026 | 0.483 | 0.49 | 0.4556 | 0.458 | 26678.00 |
| Aug 31, 2026 | 0.441 | 0.4705 | 0.441 | 0.4611 | 8407.00 |
| Aug 28, 2026 | 0.4437 | 0.46 | 0.442 | 0.4437 | 6732.00 |
| Aug 27, 2026 | 0.44 | 0.4605 | 0.44 | 0.441 | 51334.00 |
| Aug 26, 2026 | 0.447 | 0.4877 | 0.44 | 0.4401 | 13095.00 |
| Aug 25, 2026 | 0.474 | 0.489 | 0.44 | 0.4602 | 53829.00 |
| Aug 24, 2026 | 0.4544 | 0.4776 | 0.4511 | 0.453 | 14207.00 |
| Aug 21, 2026 | 0.4383 | 0.48 | 0.4383 | 0.48 | 22755.00 |
| Aug 20, 2026 | 0.4302 | 0.4588 | 0.4302 | 0.4493 | 24412.00 |
| Aug 19, 2026 | 0.4558 | 0.4629 | 0.4332 | 0.4332 | 31399.00 |
| Aug 18, 2026 | 0.4595 | 0.4772 | 0.459 | 0.47 | 26643.00 |
| Aug 17, 2026 | 0.44 | 0.479 | 0.44 | 0.4774 | 54607.00 |
| Aug 14, 2026 | 0.42 | 0.4841 | 0.4145 | 0.4593 | 51126.00 |
| Aug 13, 2026 | 0.4482 | 0.4482 | 0.43 | 0.44 | 6963.00 |
| Aug 12, 2026 | 0.43 | 0.447 | 0.43 | 0.447 | 14421.00 |
| Aug 11, 2026 | 0.4342 | 0.448 | 0.43 | 0.43 | 81672.00 |
| Aug 10, 2026 | 0.4345 | 0.4399 | 0.4111 | 0.4355 | 27475.00 |
| Aug 07, 2026 | 0.45 | 0.45 | 0.4334 | 0.4351 | 9360.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| LENZ Therapeutics, Inc. | 4.52 |
| Enveric Biosciences, Inc. | 1.42 |
| ANI Pharmaceuticals, Inc. | 70.19 |
| Corcept Therapeutics, Inc. | 112.79 |
| Veru, Inc. | 2.44 |
Price Related Metrics
| PS Ratio | 1092.69 |
| Price to Book Value | 4.609 |
| Earnings Yield | -21.34% |
| Market Cap | 49.62M |